Gilead Sciences, Inc. (GILD)
NASDAQ: GILD · Real-Time Price · USD
124.57
+0.81 (0.65%)
Jun 22, 2026, 3:38 PM EDT - Market open
Gilead Sciences Income Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| 29,736 | 29,443 | 28,754 | 27,116 | 27,281 | 27,305 | |
Revenue Growth (YoY) | 3.48% | 2.40% | 6.04% | -0.60% | -0.09% | 10.60% |
Cost of Revenue | 6,139 | 6,234 | 6,251 | 6,498 | 5,657 | 6,601 |
Gross Profit | 23,597 | 23,209 | 22,503 | 20,618 | 21,624 | 20,704 |
Selling, General & Admin | 5,967 | 5,774 | 6,091 | 6,090 | 5,673 | 5,246 |
Research & Development | 7,260 | 7,413 | 14,750 | 6,923 | 8,621 | 5,540 |
Total Operating Expenses | 13,227 | 13,187 | 20,841 | 13,013 | 14,294 | 10,786 |
Operating Income | 10,371 | 10,022 | 1,662 | 7,605 | 7,330 | 9,918 |
Interest Expense | -1,005 | -1,024 | -977 | -944 | -935 | -1,001 |
Other Non-Operating Income (Expense) | 1,012 | 798 | 6 | 198 | -581 | -639 |
Total Non-Operating Income (Expense) | 7 | -226 | -971 | -746 | -1,516 | -1,640 |
Pretax Income | 10,728 | 9,796 | 690 | 6,859 | 5,814 | 8,278 |
Provision for Income Taxes | 1,511 | 1,286 | 211 | 1,247 | 1,248 | -2,077 |
Net Income | 9,216 | 8,510 | 480 | 5,613 | 4,566 | 6,201 |
Minority Interest in Earnings | - | - | - | -52 | -26 | 24 |
Net Income to Common | 7,195 | 8,510 | 480 | 5,665 | 4,592 | 6,225 |
Net Income Growth | 54.73% | 1672.92% | -91.53% | 23.37% | -26.23% | 4960.98% |
Shares Outstanding (Basic) | 1,243 | 1,244 | 1,247 | 1,248 | 1,255 | 1,256 |
Shares Outstanding (Diluted) | 1,254 | 1,255 | 1,255 | 1,258 | 1,262 | 1,262 |
Shares Change (YoY) | -0.14% | - | -0.24% | -0.32% | - | -0.08% |
EPS (Basic) | 7.42 | 6.84 | 0.38 | 4.54 | 3.66 | 4.96 |
EPS (Diluted) | 7.34 | 6.78 | 0.38 | 4.50 | 3.64 | 4.93 |
EPS Growth | 54.53% | 1684.21% | -91.56% | 23.63% | -26.17% | 4830.00% |
Free Cash Flow | 5,295 | 9,456 | 10,305 | 7,421 | 8,344 | 10,805 |
Free Cash Flow Growth | -44.00% | -8.24% | 38.86% | -11.06% | -22.78% | 40.40% |
Free Cash Flow Per Share | 4.22 | 7.53 | 8.21 | 5.90 | 6.61 | 8.56 |
Dividends Per Share | 3.190 | 3.160 | 3.080 | 3.000 | 2.920 | 2.840 |
Dividend Growth | 0.95% | 2.60% | 2.67% | 2.74% | 2.82% | 4.41% |
Gross Margin | 79.36% | 78.83% | 78.26% | 76.04% | 79.26% | 75.82% |
Operating Margin | 34.88% | 34.04% | 5.78% | 28.05% | 26.87% | 36.32% |
Profit Margin | 30.99% | 28.90% | 1.67% | 20.70% | 16.74% | 22.71% |
FCF Margin | 17.81% | 32.12% | 35.84% | 27.37% | 30.59% | 39.57% |
EBITDA | 13,124 | 12,782 | 4,429 | 10,298 | 9,433 | 11,968 |
EBITDA Margin | 44.14% | 43.41% | 15.40% | 37.98% | 34.58% | 43.83% |
EBIT | 10,371 | 10,022 | 1,662 | 7,605 | 7,330 | 9,918 |
EBIT Margin | 34.88% | 34.04% | 5.78% | 28.05% | 26.87% | 36.32% |
Effective Tax Rate | 14.08% | 13.13% | 30.58% | 18.18% | 21.47% | -25.09% |